EN
HI
Neuland Laboratories Chart
Neuland Laboratories Share Key Metrics
Volume
73932.00
Market Cap
21923.71 CR
LTQ@LTP
1@17088.00
ATP
17002.06
Var Margin
22.86 %
Circuit Range
13418-20126
Delivery %
43.85 %
Value
125.70 CR
ASM/GSM
No
Market Lot
1
Summary
Neuland Laboratories share price is ₹17088 as of 29 May, 2026. The stock Neuland Laboratories intraday movement has stayed between ₹16675.00 and ₹17170.00, while on a 52-week basis,Neuland Laboratories price 52 week high is ₹19747.00 & its 52 week low is ₹11011.00.
In terms of trading activity, Neuland Laboratories has recorded a volume of 73932 shares, The Neuland Laboratories has a market cap of ₹12829889 CR. The stock’s Average Traded Price (ATP) stands at ₹17002.06, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 1 @ ₹17088.00.
Neuland Laboratories operates within a circuit range of ₹13418.00 – ₹20126.00, with a Value of ₹125.70 CR. The Delivery Percentage for the day is 43.85%. Additionally, Neuland Laboratories currently falls under the No framework, and trades with a market lot size of 1.
Neuland Laboratories Fundamentals
View MoreP/E Ratio
59.07
P/B Ratio
11.48
Div. Yield
0.2
Sector P/E
55.51
Sector P/B
3.01
Sec. Div. Yield
0.55
Neuland Laboratories Resistance and Support
Pivot 16947.33
Resistance
First Resistance
17184.66
Second Resistance
17597.33
Third Resistance
17834.66
Support
First Support
16534.66
Second Support
16297.33
Third Support
15884.66
Neuland Laboratories Corporate Actions
| Date | Agenda |
|---|---|
| 2026-05-12 | Audited Results & Final Dividend |
| 2026-02-09 | Quarterly Results |
| 2025-11-07 | Quarterly Results |
| 2025-07-31 | Quarterly Results |
| 2025-05-15 | Audited Results & Final Dividend |
| 2025-02-10 | Quarterly Results |
Neuland Laboratories News
Neuland Laboratories Limited
Neuland Laboratories released the transcript for its Q4 & FY26 earnings call held on May 12, 2026. The company reported a significant increase in Q4 revenue and net profit, with full year revenue growing 37.1%.
May 16 2026 16:12:57
Neuland Laboratories shares rally 7% as profit jumps seven-fold and revenue doubles in Q4
Neuland Laboratories reported a significant increase in its Q4 financial performance, with profit jumping seven-fold and revenue doubling. This strong quarterly update led to a 7% rally in the company's shares.
May 13 2026 10:36:41
Read More
Neuland Laboratories Management
| Name | Position |
|---|---|
| Davuluri Rama Mohan Rao | Chairman |
| Davuluri Sucheth Rao | Vice Chairman |
Neuland Laboratories Similar Stocks
Wockhardt Ltd.
2031.40
260.40 (14.70%)
Dr. Lal Pathlabs Ltd.
1607.40
-9.80 (0.61%)
Acutaas Chemicals Ltd.
3132.50
131.90 (4.40%)
Sai Life Sciences Ltd.
1160.00
28.80 (2.55%)
Piramal Pharma Ltd.
172.79
-1.45 (0.83%)
Pfizer Ltd.
4598.50
-24.10 (0.52%)
Natco Pharma Ltd.
1015.90
-159.90 (13.60%)
Onesource Specialty Pharma Ltd.
1824.60
33.50 (1.87%)
Granules India Ltd.
773.85
-8.75 (1.12%)
Astrazeneca Pharma India Ltd.
8631.50
-16.50 (0.19%)
Neuland Laboratories FAQs
The Buying Price of Neuland Laboratories share is 17088 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Neuland Laboratories stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Neuland Laboratories, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Neuland Laboratories shares is 59.07. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Neuland Laboratories shares is 11.48. Useful to assess the stock's value relative to its book value.
To assess Neuland Laboratories’s valuation compare Sector P/E, P/B which are 55.51 & 3.01 with sector averages, along with growth rates and financial metrics.
The Market Cap of Neuland Laboratories is 21923.71 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Neuland Laboratories share price is 19747.00 & 11011.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Neuland Laboratories belongs to the Healthcare sector.
